INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994 | +235.8% | 31,436 | +333.1% | 0.01% | +350.0% |
| Q2 2023 | $296 | -14.9% | 7,258 | -27.3% | 0.00% | -60.0% |
| Q4 2022 | $348 | -100.0% | 9,982 | -41.9% | 0.01% | -61.5% |
| Q3 2022 | $962,000 | +135.2% | 17,186 | +117.5% | 0.01% | +160.0% |
| Q2 2022 | $409,000 | -67.4% | 7,903 | -54.2% | 0.01% | -68.8% |
| Q1 2022 | $1,253,000 | +169.5% | 17,243 | +397.3% | 0.02% | +166.7% |
| Q3 2021 | $465,000 | -6.4% | 3,467 | -62.0% | 0.01% | +20.0% |
| Q4 2020 | $497,000 | -54.3% | 9,134 | -83.3% | 0.01% | -77.3% |
| Q3 2020 | $1,088,000 | +33.2% | 54,723 | +40.7% | 0.02% | +4.8% |
| Q2 2020 | $817,000 | +366.9% | 38,882 | +197.1% | 0.02% | +250.0% |
| Q3 2019 | $175,000 | – | 13,089 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |